Skip to main content
Livermore
Livermore
ZHEN

Semnur Pharmaceuticals, Inc.

SMNR
Exchange
OTC
Industry
Pharmaceutical Preparations
SEC CIK
0001913577

No open-market purchases or sales by Semnur Pharmaceuticals, Inc. insiders were filed in the last 90 days; 2 institutions reported holding it in 13F filings for Q2 2026, worth $73 in total; no superinvestor holds it.

Other share classesSMNRW

Holders of 5% or more of SMNR

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Semnur Pharmaceuticals, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SMNR
HolderLatest formStakeChangeFirst filedLatest filingFiling
Scilex Holding Co13D/A78.85%181.5M shares−3.22 ppfrom 82.07%Sep 9, 20243 filingsJun 26, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

33 Schedule 13D and 13G filings on Semnur Pharmaceuticals, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SMNR
Filed (ET)FilerFormStakeChangeEvent dateFiling
Jun 26, 20264:24 PM ETScilex Holding Coand 1 other13D/A78.85%181.5M shares−3.22 ppfrom 82.07%Jun 15, 2026SEC
Oct 14, 20254:01 PM ETScilex Holding Coand 1 other13D/A82.07%188.6M shares–Sep 22, 2025SEC
Aug 14, 20256:11 PM ETMeteora Capital, LLC13G/A0.00%0 shares0.00 ppfrom 0.00%Below 5%Jun 30, 2025SEC
Aug 12, 202511:24 AM ETTD Securities (USA) LLCand 4 others13G/A0.00%0 shares−3.00 ppfrom 3.00%Below 5%Jun 30, 2025SEC
Jun 5, 20259:15 AM ETMeteora Capital, LLCand 1 other13G/A0.00%0 shares−38.84 ppfrom 38.84%Below 5%May 31, 2025SEC
May 15, 202512:17 PM ETMeteora Capital, LLCand 1 other13G/A38.84%490.0K shares−0.69 ppfrom 39.53%Mar 31, 2025SEC
Feb 7, 20254:10 PM ETMeteora Capital, LLCand 1 other13G/A39.53%498.8K shares–Jan 31, 2025SEC
Dec 26, 202410:54 AM ETTD Securities (USA) LLCand 4 others13G3.00%50.0K sharesNewBelow 5%Dec 16, 2024SEC
Dec 6, 2024Meteora Capital, LLC13G/AOld format–––SEC
Nov 14, 2024Polar Asset Management Partners Inc.13G/AOld format–––SEC
Nov 14, 2024Meteora Capital, LLC13G/AOld format–––SEC
Nov 14, 2024Glazer Capital, LLC13G/AOld format–––SEC
Oct 7, 2024Calamos Investment Trust13G/AOld format–––SEC
Sep 16, 2024Denali Capital Global Investments LLC13G/AOld format–––SEC
Sep 9, 2024Scilex Holding Co13DOld format–New–SEC
Aug 9, 2024Meteora Capital, LLC13GOld format–––SEC
Feb 22, 2024Shaolin Capital Management LLC13G/AOld format–––SEC
Feb 14, 2024Calamos Investment Trust13GOld format–New–SEC
Feb 14, 2024Glazer Capital, LLC13GOld format–New–SEC
Feb 13, 2024Atw Spac Management LLC13G/AOld format–––SEC
Feb 13, 2024Boothbay Fund Management, LLC13G/AOld format–––SEC
Feb 13, 2024Polar Asset Management Partners Inc.13G/AOld format–––SEC
Feb 2, 2024Hudson Bay Capital Management LP13G/AOld format–––SEC
Nov 7, 2023Meteora Capital, LLC13GOld format–New–SEC
May 16, 2023Denali Capital Global Investments LLC13GOld format–New–SEC
Feb 14, 20237:29 AM ETMizuho Financial Group Inc13GOld format–New–SEC
Feb 14, 2023Shaolin Capital Management LLC13GOld format–New–SEC
Feb 14, 2023Atw Spac Management LLC13GOld format–New–SEC
Feb 10, 2023Boothbay Fund Management, LLC13GOld format–New–SEC
Feb 10, 2023Polar Asset Management Partners Inc.13GOld format–New–SEC
Feb 7, 2023Hudson Bay Capital Management LP13GOld format–New–SEC
Jan 31, 2023Feis Lawrence13G/AOld format–––SEC
Oct 20, 2022Feis Lawrence13GOld format–New–SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Semnur Pharmaceuticals, Inc. shares.

No Form 144 notices for Semnur Pharmaceuticals, Inc. are on file.